Dr. Kyle Keith Vankoevering, MD

Dr. Vankoevering practices at OSU Eye and Ear Institute in Columbus, Ohio.

Dr. Vankoevering's NPI, 1750642823, was assigned on June 5, 2012. Dr. Vankoevering holds Ohio license 3513002.

Dr. Vankoevering's primary practice is OSU Eye and Ear Institute, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 366-3687.

Dr. Vankoevering's primary practice is OSU Eye and Ear Institute in Columbus, Ohio. Dr. Vankoevering is also affiliated with Ohio State University Hospital. The medical group on file is OSU Otolaryngology Head & Neck Surgery. Dmand AI also links Dr. Vankoevering to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vankoevering practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Vankoevering's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Vankoevering's licenses on file in 2 states: Ohio and Michigan.

CMS data shows 340 Medicare services from Dr. Vankoevering across 6 procedure codes in 2024, for 130 Medicare patients. Medicare paid $29,533 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 130 Medicare patients who saw Dr. Vankoevering in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vankoevering's median patient age at 66, with 43% women.

In 2024, Dr. Vankoevering wrote 16 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $93 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

Dr. Vankoevering accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vankoevering as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 76 papers to Dr. Vankoevering, published from 2012 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Printing, Three-Dimensional, Skull Base and Models, Anatomic. Dr. Vankoevering has published most often in Oral Oncol. Dr. Vankoevering's most frequent co-authors are Ricardo L. Carrau, MD, Nolan B. Seim, MD and Matthew Owen Old, MD.

Dmand AI links Dr. Vankoevering to 2 clinical trials. Conditions studied include Craniofacial Abnormalities, Maxillofacial Abnormalities and Musculoskeletal Abnormalities.

CMS Open Payments shows 19 general payments to Dr. Vankoevering from 5 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 87% of the total. KLS-Martin L.P. paid the most, $9,339.